6533b7dcfe1ef96bd127279e
RESEARCH PRODUCT
Clinical utility of plasma-based digital next-generation sequencing (NGS) in patients with advance-stage lung adenocarcinomas with insufficient tumor samples for tissue genotyping.
Oscar Juan VidalJavier De CastroEnriqueta FelipReyes Bernabe CaroInmaculada Ramos GarciaPilar Garrido LopezEloisa Jantus-lewintreRichard B. LanmanIris FaullRosario Garcia CampeloCarlos CampsLuis Paz-aresJose Miguel Sanchez TorresJose Manuel Trigo PerezMariano Provencio-pullaJon ZugazagoitiaSantiago Ponce AixMagda PalkaAna Gómez RuedaDolores Islasubject
OncologyCancer Researchmedicine.medical_specialtyLungbusiness.industryDNA sequencingSubtypingInsufficient Tissuemedicine.anatomical_structureOncologyInternal medicineMedicineIn patientStage (cooking)businessGenotypingdescription
9101Background: Approximately 20 % of tumor biopsies from patients with advanced-stage lung adenocarcinomas yield insufficient tissue for successful molecular subtyping. In this study, we have anal...
year | journal | country | edition | language |
---|---|---|---|---|
2018-05-20 | Journal of Clinical Oncology |